LinkedIn Profile

Access Kiromic historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Sector Industry
private:kiromic 3341795 May 29th, 2019 12:00AM Kiromic 772 15.00 Open Biotechnology May 29th, 2019 09:01AM May 29th, 2019 09:01AM Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. Our cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times. Open Cancer Research, Tumor Immunology, Cell Culture, Biopharmaceutical, Nanotechnology Open 6104 45th Street, Suite D Lubbock TX US 79407 Pharmaceuticals & Biotechnology
private:kiromic 3341795 Mar 18th, 2018 12:00AM Kiromic 743 17.00 Open Biotechnology Mar 18th, 2018 06:43PM Mar 18th, 2018 06:43PM Open Pharmaceuticals & Biotechnology
private:kiromic 3341795 Feb 17th, 2018 12:00AM Kiromic 740 18.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. Our cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times. Pharmaceuticals & Biotechnology
private:kiromic 3341795 Feb 16th, 2018 12:00AM Kiromic 740 18.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. Our cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times. Pharmaceuticals & Biotechnology
private:kiromic 3341795 Feb 15th, 2018 12:00AM Kiromic 740 18.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. Our cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times. Pharmaceuticals & Biotechnology
private:kiromic 3341795 Feb 14th, 2018 12:00AM Kiromic 740 18.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. Our cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times. Pharmaceuticals & Biotechnology
private:kiromic 3341795 Feb 13th, 2018 12:00AM Kiromic 740 18.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. Our cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times. Pharmaceuticals & Biotechnology
private:kiromic 3341795 Feb 12th, 2018 12:00AM Kiromic 740 18.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. Our cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times. Pharmaceuticals & Biotechnology
private:kiromic 3341795 Feb 11th, 2018 12:00AM Kiromic 740 18.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. Our cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times. Pharmaceuticals & Biotechnology
private:kiromic 3341795 Feb 10th, 2018 12:00AM Kiromic 740 18.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. Our cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times. Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.